These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 2830329)
1. Delta-9-tetrahydrocannabinol inhibits the splenocyte proliferative response to herpes simplex virus type 2. Cabral GA; McNerney PJ; Mishkin EM Immunopharmacol Immunotoxicol; 1987; 9(2-3):361-70. PubMed ID: 2830329 [TBL] [Abstract][Full Text] [Related]
2. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors. Schmid DS; Rouse BT J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080 [TBL] [Abstract][Full Text] [Related]
3. Effect of micromolar concentrations of delta-9-tetrahydrocannabinol on herpes simplex virus type 2 replication in vitro. Cabral GA; McNerney PJ; Mishkin EM J Toxicol Environ Health; 1987; 21(3):277-93. PubMed ID: 3035199 [TBL] [Abstract][Full Text] [Related]
4. Lymphocyte transformation for the detection of herpesvirus-induced tumor-associated antigens. Harris LF; Hamparian VV; Young EA; Hughes JH Cancer Res; 1979 Oct; 39(10):3996-4002. PubMed ID: 225013 [TBL] [Abstract][Full Text] [Related]
5. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities. Yasukawa M; Zarling JM J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243 [TBL] [Abstract][Full Text] [Related]
6. Immunity to herpes simplex virus type 2. Suppression of virus-induced immune responses in ultraviolet B-irradiated mice. Yasumoto S; Hayashi Y; Aurelian L J Immunol; 1987 Oct; 139(8):2788-93. PubMed ID: 2821119 [TBL] [Abstract][Full Text] [Related]
7. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes. Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457 [TBL] [Abstract][Full Text] [Related]
8. Effects of in vivo depletion of immunocyte populations on herpes simplex virus glycoprotein D vaccine-induced resistance to HSV2 challenge. Mishkin EM; Blasiak M; Giorgio D; Ishizaka ST Viral Immunol; 1992; 5(2):151-61. PubMed ID: 1319710 [TBL] [Abstract][Full Text] [Related]
9. Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol. Buchweitz JP; Karmaus PW; Williams KJ; Harkema JR; Kaminski NE J Leukoc Biol; 2008 Mar; 83(3):785-96. PubMed ID: 18073275 [TBL] [Abstract][Full Text] [Related]
10. Frequency of herpes simplex virus-specific helper T lymphocyte precursors in the lymph node cells of infected mice. Prymowicz D; Moore RN; Rouse BT J Immunol; 1985 Apr; 134(4):2683-8. PubMed ID: 2579150 [TBL] [Abstract][Full Text] [Related]
11. Modulation of airway responses to influenza A/PR/8/34 by Delta9-tetrahydrocannabinol in C57BL/6 mice. Buchweitz JP; Karmaus PW; Harkema JR; Williams KJ; Kaminski NE J Pharmacol Exp Ther; 2007 Nov; 323(2):675-83. PubMed ID: 17726158 [TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets. Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521 [TBL] [Abstract][Full Text] [Related]
13. Clonal analysis of T-cell responses to herpes simplex virus: isolation, characterization and antiviral properties of an antigen-specific helper T-cell clone. Leung KN; Nash AA; Sia DY; Wildy P Immunology; 1984 Dec; 53(4):623-33. PubMed ID: 6209206 [TBL] [Abstract][Full Text] [Related]
14. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors. Colmenares C; Lopez C J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891 [TBL] [Abstract][Full Text] [Related]
15. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity. Nash AA; Ashford NP Immunology; 1982 Apr; 45(4):761-7. PubMed ID: 6279490 [TBL] [Abstract][Full Text] [Related]
16. Spleen cell-mediated cytotoxicity of hamster cells transformed by Herpes simplex virus: evidence for virus-specific membrane antigen. Lausch RN; Jones C; Christie D; Hay KA; Rapp F J Immunol; 1975 Jan; 114(1 Pt 2):459-65. PubMed ID: 163859 [TBL] [Abstract][Full Text] [Related]
17. Murine epidermal antigen-presenting cells in primary and secondary T-cell proliferative responses to herpes simplex virus in vitro. Williams NA; Hill TJ; Hooper DC Immunology; 1991 Jan; 72(1):34-9. PubMed ID: 1847693 [TBL] [Abstract][Full Text] [Related]
18. Contrasting effects of THC on adult murine lymph node and spleen cell populations stimulated with mitogen or anti-CD3 antibody. Pross SH; Nakano Y; McHugh S; Widen R; Klein TW; Friedman H Immunopharmacol Immunotoxicol; 1992; 14(3):675-87. PubMed ID: 1325494 [TBL] [Abstract][Full Text] [Related]